<!-- received="Tue Dec  7 11:11:47 1999 MST" -->
<!-- sent="Tue, 7 Dec 1999 13:02:12 -0500" -->
<!-- name="John Clark" -->
<!-- email="jonkc@worldnet.att.net" -->
<!-- subject="Telomerase and cancer" -->
<!-- id="005301bf40dd$3d2ef1a0$289c4d0c@flrjs" -->
<!-- inreplyto="" -->
<!-- version=1.10, linesinbody=10 -->
<html><head><title>extropians: Telomerase and cancer</title>
<meta name=author content="John Clark">
<link rel=author rev=made href="mailto:jonkc@worldnet.att.net" title ="John Clark">
</head><body>
<h1>Telomerase and cancer</h1>
John Clark (<i>jonkc@worldnet.att.net</i>)<br>
<i>Tue, 7 Dec 1999 13:02:12 -0500</i>
<p>
<ul>
<li> <b>Messages sorted by:</b> <a href="date.html#3376">[ date ]</a><a href="index.html#3376">[ thread ]</a><a href="subject.html#3376">[ subject ]</a><a href="author.html#3376">[ author ]</a>
<!-- next="start" -->
<li><a href="3377.html">[ Next ]</a><a href="3375.html">[ Previous ]</a>
<!-- nextthread="start" -->
</ul>
<!-- body="start" -->

<p>
<a name="3407qlink1"><a name="3386qlink1">The stock of Geron jumped by 48% this morning. In today's issue of
The Proceedings Of The national Academy Of Science researchers
from that company wrote an article that shows that "inhibitors of
telomerase can remortalize human cancer cells", in other words,
they can make cancer die of old age, at least in the lab.</a>

<p>
   John K Clark        jonkc@att.net
</a>
<!-- body="end" -->
<p>
<ul>
<!-- next="start" -->
<li><a href="3377.html">[ Next ]</a><a href="3375.html">[ Previous ]</a>
<!-- nextthread="start" -->
</ul>
</body></html>
